Innovating Works

ICELLATE MEDICAL AB

Desconocido
DeteCTCs: The first multi cancer liquid biopsy test for detection of early stage cancer and minimal residual d... ICELLATE MEDICAL AB tramitó un H2020: H2020-EIC-FTI-2018-2020 With over 10M deaths and an annual cost of €199B, cancer poses an immense burden on individuals, healthcare, and society. To reduce cancer d...
2021-06-01 - 2024-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.